Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report. Keep reading to find out more.
Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report, which offers a snapshot of the specialty pharmacy market's evolving trends, as well as solutions for managing costs and improving care.
The report is available online at
FDA Approves Second Formulation of Humira Biosimilar Cyltezo
May 1st 2024According to Michael Osso, president and chief executive officer of the Crohn’s & Colitis Foundation, “the flexibility of having multiple biosimilar formulations to choose from is important to support broader patient access to biologic medicine.”